Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea?
- PMID: 25953386
- DOI: 10.1007/s11325-015-1179-x
Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea?
Abstract
Background: Surfactant proteins B and C are mainly synthesized, secreted by alveolar type II cells, and affected by hypoxia and mechanical stretches. We hypothesized that their serum levels might be altered by intermittent hypoxia and swing of intrathoracic pressure of obstructive sleep apnea (OSA).
Methods: Consecutive 140 middle-aged males, suspicious of OSA determined by polysomnography, were studied. Surfactant proteins B and C were determined by ELISA.
Results: Surfactant protein B (41.39 ± 6.01 vs 44.73 ± 7.62 ng/L, p = 0.005), not C (32.60 ± 6.00 vs 32.43 ± 6.44 ng/L, p = 0.61), significantly lowered in moderate to severe OSA subjects than in non to mild OSA subjects. Severity of OSA is inversely correlated with serum surfactant protein B. Adjusting age, body mass index, and smoking history, compared to subjects with surfactant protein B (SP-B) ≥43.35 ng/L, those with SP-B <43.35 ng/L showed significantly increased 1.528-fold risk for moderate to severe OSA (p = 0.009), whereas no association between surfactant protein C and OSA was observed. Prevalence of moderate to severe OSA in lower SP-B group is higher than that in higher SP-B group (62.7 vs 38.4 %, p = 0.003). Serial and parallel tests on Epworth sleep scale (ESS) and SP-B evaluation can be complementary and prove helpful with high specificity (94.44 %) and sensitivity (84.48 %) to detect moderate to severe OSA.
Conclusions: Serum surfactant protein B, rather than C, is decreased in some individuals with moderate to severe OSA, compared to non to mild OSA subjects. Serum surfactant protein B might be a potential biomarker to diagnose OSA.
Keywords: Biomarker; Obstructive sleep apnea; Surfactant protein.
Similar articles
-
What do changes in concentrations of serum surfactant proteins A and D in OSA mean?Sleep Breath. 2015 Sep;19(3):955-62. doi: 10.1007/s11325-014-1106-6. Epub 2015 Jan 27. Sleep Breath. 2015. PMID: 25619705
-
Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome?J Craniomaxillofac Surg. 2015 Jul;43(6):879-82. doi: 10.1016/j.jcms.2015.03.031. Epub 2015 Apr 3. J Craniomaxillofac Surg. 2015. PMID: 25957103
-
Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea.Respir Med. 2011 Jun;105(6):939-45. doi: 10.1016/j.rmed.2011.02.016. Epub 2011 Mar 12. Respir Med. 2011. PMID: 21402472
-
Is C-reactive protein a marker of obstructive sleep apnea?: A meta-analysis.Medicine (Baltimore). 2017 May;96(19):e6850. doi: 10.1097/MD.0000000000006850. Medicine (Baltimore). 2017. PMID: 28489776 Free PMC article. Review.
-
Vitamin D and obstructive sleep apnea: a systematic review and meta-analysis.Sleep Med. 2018 Mar;43:100-108. doi: 10.1016/j.sleep.2017.10.016. Epub 2017 Dec 14. Sleep Med. 2018. PMID: 29482804
Cited by
-
Genetic variants of rs1275988 and rs2586886 in TWIK-related acid-sensitive K+ channel-1 gene may be potential risk factors for obese patients with obstructive sleep apnea.Chin Med J (Engl). 2019 Sep 5;132(17):2059-2065. doi: 10.1097/CM9.0000000000000401. Chin Med J (Engl). 2019. PMID: 31436597 Free PMC article.
-
Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea.Sleep Breath. 2018 Mar;22(1):99-107. doi: 10.1007/s11325-017-1536-z. Epub 2017 Jul 13. Sleep Breath. 2018. PMID: 28707162
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous